{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:20:36Z","timestamp":1788178836174,"version":"build-2803163510"},"reference-count":33,"publisher":"Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:p>Background: Liver cancer is a leading cause of cancer-related mortality worldwide. Clinical use of the first-line drug sorafenib is limited due to drug resistance and severe adverse effects. Objectives: The current study aimed to synthesize a series of N-arylated thiophene-based 1,3,4-oxadiazole derivatives containing a carbamothioate moiety (7a-7d) as potential anticancer agents with improved efficacy and safety profiles. Methods: Derivatives were synthesized via coupling of thiophene-based 1,3,4-oxadiazole (compound 1) with various electrophiles, yielding 62-86%. The structures of all derivatives were established based on FT-IR, 1H NMR, 13C NMR, and EI-MS. The in-vitro anticancer effect of all derivatives was assessed using the MTT assay against the HepG2 cancer cell line and their hemolytic safety was assessed on human red blood cells. Results: All derivatives exhibited cytotoxicity with minimal hemolytic effects. Derivative 7b (2,6-dimethyl) exhibited excellent activity by reducing cell viability of 33.96 \u00b1 2.47% at 100 ?g\/mL and minimal hemolysis (1.20 \u00b1 0.01%) with a high selectivity index (SI) of 28.3, similar to sorafenib (34.32 \u00b1 1.91%, SI = 27.45). Derivatives 7a (phenyl) and 7d (ethyl) showed moderate activity and 7c (fluoro) was the least potent. Conclusion: Thiophene-based oxadiazole-coupled carbamothioate derivatives, particularly 7b, demonstrate enhanced anticancer efficacy and safety compared to sorafenib, representing promising candidates for targeted liver cancer therapy.<\/jats:p>","DOI":"10.36721\/pjps.2026.39.7.182.1","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:04:01Z","timestamp":1779357841000},"source":"Crossref","is-referenced-by-count":0,"title":["Synthesis And Biological Evaluation Of Thiophene Based Oxadiazole Derivatives As Promising Anticancer Agents Against Liver Cancer"],"prefix":"10.36721","author":[{"given":"Zainib","family":"Razzaq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22735","published-online":{"date-parts":[[2026,4,19]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"Abbas AA, Farghaly TA and Dawood KM (2024). Recent advances on anticancer and antimicrobial activities of directly-fluorinated five-membered heterocycles and their benzo-fused systems. RSC Adv., 14(28): 19752-19779.","DOI":"10.1039\/D4RA01387E"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Al-Najdawi MM, Saleh MM, Sabbah DA, Hajjo R, Zalloum H, Abudoleh SM, Abuarqoub DA, Al-Hiari YM, Mohammad MY, ALSalamat H, Mansour H, Aljbour ND and Mestareehi AH (2025). Exploring carboxamide derivatives as promising anticancer agents: Design, in-vitro evaluation and mechanistic insights. Int. J. Mol. Sci., 26(12): 5903.","DOI":"10.3390\/ijms26125903"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Almatari AS, Saeed A, Abdel-Ghani GE, Abdullah MMS, Al-Lohedan HA, Abdel-Latif E and El-Demerdash A (2024). Synthesis of some novel thiophene analogues as potential anticancer agents. Chem. Biodivers., 21(7): e202400313.","DOI":"10.1002\/cbdv.202400313"},{"key":"ref3","unstructured":"Alderawy MQA, Alrubaie LAR and Sheri FH (2020). Synthesis, characterization of ibuprofen N-acyl-1,3,4-oxadiazole derivatives and anticancer activity against MCF-7 cell line. Syst. Rev. Pharm., 11(4): 681-689."},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Akhter N, Batool S, Khan SG, Rasool N, Anjum F, Rasul A and Imran S (2023). Bio-oriented synthesis and molecular docking studies of 1,2,4-triazole based derivatives as potential anti-cancer agents against HepG2 cell line. Pharmaceuticals, 16(2): 211.","DOI":"10.3390\/ph16020211"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Bajaj S, Kumar MS, Tinwala H and Yc M (2021). Design, synthesis, modelling studies and biological evaluation of 1,3,4-oxadiazole derivatives as potent anticancer agents targeting thymidine phosphorylase enzyme. Bioorg. Chem., 111: 104873.","DOI":"10.1016\/j.bioorg.2021.104873"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Benassi A, Doria F and Pirota V (2020). Groundbreaking anticancer activity of highly diversified oxadiazole scaffolds. Int. J. Mol. Sci., 21(22): 8692.","DOI":"10.3390\/ijms21228692"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Bin Muhsinah A, Alharbi MM, Kheder NA, Soliman SM, Ghabbour HA, Mahmoud NS, Elhaty IA and Mabkhot YN (2024). New thiophene derivatives: Chemoselective synthesis, antitumor effectiveness, structural characterization, DFT calculations, Hirshfeld surface and Fukui function analysis. BMC Chem., 18(1): 228.","DOI":"10.1186\/s13065-024-01346-5"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Feng Gh, Yue Qq, Zhao Kh, Peng T, Tang T, Sun Yx, Meng Xr, Huang Ll, Zeng X and Zeng Y (2024). Factors affecting the compliance of hepatocellular carcinoma screening among high-risk populations: A systematic review and meta-analysis. Public Health Nurs., 41(3): 476-486.","DOI":"10.1111\/phn.13298"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Gul S, Abbasi MA, Khan KM, Nafeesa K, Siddiqa A, Akhtar MN and Subhani Z (2017). Synthesis, antimicrobial evaluation and hemolytic activity of 2-[[5-alkyl\/aralkyl substituted-1,3,4-oxadiazol-2-yl]thio]-N-[4-(4-morpholinyl)phenyl]acetamide derivatives. J. Saudi Chem. Soc., 21: S425-S433.","DOI":"10.1016\/j.jscs.2014.04.005"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Hawash M, Abdallah S, Abudayyak M, Melhem Y, Abu Shamat M, Aghbar M, Capan I, Abualhasan M, Kumar A, Kaminski M, Goral T, Dominiak PM and Sobuh S (2024). Exploration of isoxazole analogs: Synthesis, COX inhibition, anticancer screening, 3D multicellular tumor spheroids and molecular modeling. Eur. J. Med. Chem., 271: 116397.","DOI":"10.1016\/j.ejmech.2024.116397"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Hussain S, Javed W, Tajammal A, Khalid M, Rasool N, Riaz M and Shah SAA (2023). Synergistic antibacterial screening of Cymbopogon citratus and Azadirachta indica: Phytochemical profiling and antioxidant and hemolytic activities. ACS omega, 8(19): 16600-16611.","DOI":"10.1021\/acsomega.2c06785"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Irfan M, Khan HA, Bibi S, Wu G, Ali A, Khan, SG, and Chen K (2024). Exploration of nonlinear optical properties of 4-methyl-4H-1,2,4-triazol-3-yl) thio)-N-phenylpropanamide based derivatives: Experimental and DFT approach. Sci. Rep., 14(1): 2732.","DOI":"10.1038\/s41598-024-51788-z"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Javed MS, Zubair M, Rizwan K and Jamil M (2023). In-vitro anti-microbial activity and anti-cancer potential of novel synthesized carbamothioyl-furan-2-carboxamide derivatives. Molecules, 28(12): 4583.","DOI":"10.3390\/molecules28124583"},{"key":"ref14","unstructured":"Khan SG, Bokhari TH, Anjum F, Akhter N, Rasool S, Shah SAA, Shahid M and Arshad A (2020). Synthesis, characterization, antibacterial, hemolytic and thrombolytic activity evaluation of 5-(3-chlorophenyl)-2-((N-(substituted)-2-acetamoyl) sulfanyl)-1,3,4-oxadiazole derivatives. Pak. J. Pharm. Sci., 33(1): 871\u2013876."},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Khedkar NR, Sindkhedkar M and Joseph A (2024). Computational design, synthesis and assessment of 3-(4-(4-(1,3,4-oxadiazol-2-yl)-1H-imidazol-2-yl)phenyl)-1,2,4-oxadiazole derivatives as effective epidermal growth factor receptor inhibitors: A prospective strategy for anticancer therapy. RSC Med. Chem., 15(5): 1626-1639.","DOI":"10.1039\/D4MD00055B"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Liang Y (2024). Mechanisms of sorafenib resistance in hepatocellular carcinoma. Clin. Res. Hepatol. Gastroenterol., 48(8): 102434.","DOI":"10.1016\/j.clinre.2024.102434"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Mara BI, Mioc A, Deveseleanu-Corici LN, Soica C and Cseh L (2025). Novel compounds featuring a thiophene carboxamide scaffold: Synthesis, characterization and antiproliferative evaluation. Int. J. Mol. Sci., 26(14): 6823.","DOI":"10.3390\/ijms26146823"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Mughees M, Kaushal JB, Sharma G, Wajid S, Batra SK and Siddiqui JA (2022). Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis. Semin. Cancer Biol., 86(Pt 3): 497-512.","DOI":"10.1016\/j.semcancer.2022.02.017"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Mahmood S, Khan SG, Rasul A, Christensen JB and Abourehab MA (2022). Ultrasound assisted synthesis and in silico modelling of 1,2,4-triazole coupled acetamide derivatives of 2-(4-isobutyl phenyl) propanoic acid as potential anticancer agents. Molecules, 27(22): 7984.","DOI":"10.3390\/molecules27227984"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Naseer A, Osra FA, Awan AN, Imran A, Hameed A, Ali Shah SA, Iqbal J and Zakaria ZA (2022). Exploring novel pyridine carboxamide derivatives as urease inhibitors: Synthesis, molecular docking, kinetic studies and ADME profile. Pharmaceuticals, 15(10): 1288.","DOI":"10.3390\/ph15101288"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Rasool N, Razzaq Z, Gul Khan S, Javaid S, Akhtar N, Mahmood S, Christensen JB, Ali Altaf A, Muhammad Muneeb Anjum S, Alqahtani F, AlAsmari AF and Imran I (2023). A facile synthesis of 1,3,4-oxadiazole-based carbamothioate molecules: Antiseizure potential, EEG evaluation and in-silico docking studies. Arabian J. Chem., 16(4): 104610.","DOI":"10.1016\/j.arabjc.2023.104610"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Romagnoli R, Preti D, Hamel E, Bortolozzi R, Viola G, Brancale A, Ferla S, Morciano G and Pinton P (2021). Concise synthesis and biological evaluation of 2-aryl-3-anilinobenzo[b]thiophene derivatives as potent apoptosis-inducing agents. Bioorg. Chem., 112: 104919.","DOI":"10.1016\/j.bioorg.2021.104919"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Salem MM, Ayyad R and Sakr H (2022). Design and synthesis of some new oxadiazole derivatives as anticancer agents. Int. J. Org. Chem., 12(2): 64-74.","DOI":"10.4236\/ijoc.2022.122006"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Samanta A, Maji A, Paul A, Mishra SS, Nahar S and Maity TK (2025). 1,3,4-Oxadiazole-based EGFR inhibitors as anticancer therapeutics: SAR study and binding mode of interaction analysis. Eur. J. Med. Chem. Rep., 14: 100265.","DOI":"10.1016\/j.ejmcr.2025.100265"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Sharma U, Kumar R, Mazumder A, Salahuddin, Kukreti N, Mishra R and Chaitanya M (2024). Substrate-based synthetic strategies and biological activities of 1,3,4-oxadiazole: A review. Chem. Biol. Drug Des., 103(6): e14552.","DOI":"10.1111\/cbdd.14552"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Sonal S, Boudreau C, Lee GC, Cauley CE, Kunitake H, Goldstone RN, Francone TD, Bordeianou LG, Ricciardi R and Berger DL (2024). Causes of death in patients operated for colorectal cancer. Surgery, 175(5): 1285-1290.","DOI":"10.1016\/j.surg.2024.01.007"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 71(3): 209-249.","DOI":"10.3322\/caac.21660"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Suresh D, Srinivas AN and Kumar DP (2020). Etiology of hepatocellular carcinoma: Special focus on fatty liver disease. Front. Oncol., 10: 601710.","DOI":"10.3389\/fonc.2020.601710"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Tayanloo-Beik A, Eslami A, Sarvari M, Jalaeikhoo H, Rajaeinejad M, Nikandish M, Faridfar A, Rezaei-Tavirani M, Mafi AR, Larijani B and Arjmand B (2024). Extracellular vesicles and cancer stem cells: A deadly duo in tumor progression. Oncol. Rev., 18: 1411736.","DOI":"10.3389\/or.2024.1411736"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Thakur S, Kumar D, Jaiswal S, Goel KK, Rawat P, Srivastava V, Dhiman S, Jadhav HR and Dwivedi AR (2025). Medicinal chemistry-based perspectives on thiophene and its derivatives: Exploring structural insights to discover plausible druggable leads. RSC Med. Chem., 16(2): 481-510.","DOI":"10.1039\/D4MD00450G"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Wieczorkiewicz PA, Krygowski TM and Szatylowicz H (2024). Substituent effects and electron delocalization in five-membered N-heterocycles. Phys. Chem. Chem. Phys., 26(28): 19398-19410.","DOI":"10.1039\/D4CP01709A"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Zhou Y, Chen Y, Xuan C, Li X, Tan Y, Yang M, Cao M, Chen C, Huang X and Hu R (2024). DPP9 regulates NQO1 and ROS to promote resistance to chemotherapy in liver cancer cells. Redox Biol., 75: 103292.","DOI":"10.1016\/j.redox.2024.103292"}],"container-title":["Pakistan Journal of Pharmaceutical Sciences"],"original-title":[],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:11:19Z","timestamp":1788178279000},"score":1,"resource":{"primary":{"URL":"https:\/\/pjps.pk\/single-article?id=7785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,19]]},"references-count":33,"URL":"https:\/\/doi.org\/10.36721\/pjps.2026.39.7.182.1","relation":{},"ISSN":["1011-601X","3105-9686"],"issn-type":[{"value":"1011-601X","type":"print"},{"value":"3105-9686","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,19]]}}}